content top

New Lutein-based Dyes vs Standard Synthetic Dyes in Vitreoretinal Interface Surgery

SCIENTIFIC POSTER 2016_New Lutein-based Dyes vs Standard Synthetic Dyes in Vitreoretinal Interface Surgery Purpose: To compare anatomic, functional, microperimetric and electrofunctional outcomes among patients affected by vitreoretinal interface-associated disorders undergoing vitrectomy + epiretinal membrane and/or internal limiting membrane peeling by using new lutein-based dyes or standard synthetic dyes. Materials and Methods: This is...

Read More

Macular ILM-peeling with Lutein Enriched Dye in High Myopic Eyes

ILM-peeling is a PVR-prophylactic procedure in retinal detachment surgery. High myopia is a main risk factor for retinal detachment. ILM-peeling in high myopic eyes is a challenge even for experienced surgeons. This is due to especially strong connections between vitreous, epiretinal membrane and retinal surface. The prolonged time of ILM-peeling in high myopic eyes could increase the phototoxicity. This can result in potentially worse...

Read More

Air Endotamponade Application in Patients with Rhegmatogenous RD

SCIENTIFIC POSTER 2016_Air Endotamponade Application in Patients with Rhegmatogenous RD Katarzyna Michalska-Malecka Introduction: The aim of this research was to evaluate the results of retinal detachment treatment with pars plana vitrectomy using air endotamponade. Methods: The research was conducted among 23 patients aged from 43 to 74 years old, 9 women (39.1%) and 14 man (60.9%). All patients underwent the treatment using pars plana...

Read More

Vitrectomy and ILM Peeling With and Without Fovea-sparing IML in Bilateral Myopic Foveoschisis

SCIENTIFIC POSTER 2016_Vitrectomy and ILM Peeling With and Without Fovea-sparing IML in Bilateral Myopic Foveoschisis Natalia Ferreira The authors describe the case of a 39-year-old female, with high myopia and bilateral myopic foveoschisis. She underwent an anterior chamber phakic IOL implantation in both eyes, 6 years before. She started to complain of decreased visual acuity and metamorphopsia since a few months ago and she was referred...

Read More

Three Monthly Ranibizumab for ME Secondary to BRVO: 12-month Outcomes

Purpose: To assess 12-month efficacy of the three monthly intravitreal injections of ranibizumab for the treatment of macular oedema (MO) secondary to branch retinal vein occlusion (BRVO) in comparison with combined treatment (a single intravitreal injection of ranibizumab followed by grid laser treatment). Methods: Subjects were 19 patients (19 eyes) with unilateral vision loss attributable to macular oedema following BRVO. Duration of the...

Read More

Residual Vitreous Cortex at the Fovea During Vitrectomy for Primary Rhegmatogenous RD Repair

SCIENTIFIC POSTER 2016_Residual Vitreous Cortex at the Fovea During Vitrectomy for Primary Rhegmatogenous RD Repair Eun Hyung Cho Purpose: We investigated the effectiveness of the removal of the residual vitreous cortex in the fovea during vitrectomy for primary rhegmatogenous retinal detachment repair. Method: We retrospectively reviewed the chart and the operation video of the 50 patients (50 eyes) who underwent vitrectomy for retinal...

Read More
content top